Skip to main content
Clinical Trials/NCT05521607
NCT05521607
Recruiting
Not Applicable

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice in Newborns With High Melanin Content (Chicago)

Picterus AS1 site in 1 country250 target enrollmentJanuary 6, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neonatal Jaundice
Sponsor
Picterus AS
Enrollment
250
Locations
1
Primary Endpoint
Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Detailed Description

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) will be conducted to include a total of 250 newborns with a desired distribution of skin color according to Neomar's scale : skin color 1 and 2: 20%, skin color 3: 30% and skin color 4: 50%. The Picterus Calibration Card will be placed on the chest of the newborn with the hole in the card placed over the infant's sternum. A validated smartphone with Picterus JP will be used to collect digital images..

Registry
clinicaltrials.gov
Start Date
January 6, 2023
End Date
June 15, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infants born with gestational age \> 37 weeks.
  • Birth weight ≥ 2500 grams
  • Age 1 - 14 days
  • Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care

Exclusion Criteria

  • Infants showing signs of inborn disease.
  • Infants with skin rash or other skin disease that affects the skin where measurements are performed.
  • Infants transferred to the pediatric ward for medical treatment.
  • Infants that have received phototherapy in the last 24 hours

Outcomes

Primary Outcomes

Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Time Frame: 3-6 months

Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.

Secondary Outcomes

  • Correlate estimates of bilirubin levels obtained by Picterus JP with TSB, TcB and VA in newborns with high melanin content in the skin.(3-6 months)
  • Determine the accuracy of Picterus JP in newborns with high melanin content in the skin.(3-6 months)
  • Adapt the current algorithm of Picterus JP to newborns with high melanin content in the skin.(3-6months)

Study Sites (1)

Loading locations...

Similar Trials